Nautilus Medical

Nautilus Biotechnology is a life sciences company focused on transforming the field of proteomics through the development of a next-generation protein analysis platform. The company's technology is designed to identify and quantify the human proteome with high sensitivity and scale, utilizing a single-molecule approach that aims to overcome the limitations of traditional mass spectrometry. By providing a more comprehensive view of protein expression and modifications, Nautilus seeks to accelerate drug discovery, improve biomarker identification, and enable personalized medicine. Headquartered in San Carlos, California, the company is led by co-founders Sujal Patel and Dr. Parag Mallick and is currently in the commercialization phase of its platform.